Whitehawk Therapeutics Q2 EPS $(0.20) Beats $(0.30) Estimate
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.30) by 33.33 percent. This is a 73.68 percent increase over losses of $(0.76) per
Whitehawk lost less money than experts thought it would this quarter, and it's also losing way less than it did a year ago. When a company that's still losing money gets better at controlling its losses, that's a sign things might be heading in the right direction.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.